vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and OIL STATES INTERNATIONAL, INC (OIS). Click either name above to swap in a different company.
OIL STATES INTERNATIONAL, INC is the larger business by last-quarter revenue ($178.5M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 8.4%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 3.3%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Oil States International, Inc. is an American multinational corporation. It focuses on providing services to oil and gas companies. It is a public company listed on the New York Stock Exchange.
ESPR vs OIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $178.5M |
| Net Profit | — | $-117.2M |
| Gross Margin | — | 10.9% |
| Operating Margin | 50.6% | -63.7% |
| Net Margin | — | -65.7% |
| Revenue YoY | 143.7% | 8.4% |
| Net Profit YoY | — | -873.2% |
| EPS (diluted) | $0.32 | $-1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $178.5M | ||
| Q3 25 | $87.3M | $165.2M | ||
| Q2 25 | $82.4M | $165.4M | ||
| Q1 25 | $65.0M | $159.9M | ||
| Q4 24 | $69.1M | $164.6M | ||
| Q3 24 | $51.6M | $174.3M | ||
| Q2 24 | $73.8M | $186.4M | ||
| Q1 24 | $137.7M | $167.3M |
| Q4 25 | — | $-117.2M | ||
| Q3 25 | $-31.3M | $1.9M | ||
| Q2 25 | $-12.7M | $2.8M | ||
| Q1 25 | $-40.5M | $3.2M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $-29.5M | $-14.3M | ||
| Q2 24 | $-61.9M | $1.3M | ||
| Q1 24 | $61.0M | $-13.4M |
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 22.1% | ||
| Q2 25 | — | 24.2% | ||
| Q1 25 | — | 23.3% | ||
| Q4 24 | — | 23.7% | ||
| Q3 24 | — | 21.7% | ||
| Q2 24 | — | 23.8% | ||
| Q1 24 | — | 21.1% |
| Q4 25 | 50.6% | -63.7% | ||
| Q3 25 | -11.4% | 2.9% | ||
| Q2 25 | 8.6% | 3.2% | ||
| Q1 25 | -34.0% | 3.5% | ||
| Q4 24 | -6.4% | 11.2% | ||
| Q3 24 | -31.0% | -6.3% | ||
| Q2 24 | 3.5% | 1.1% | ||
| Q1 24 | 52.5% | -6.7% |
| Q4 25 | — | -65.7% | ||
| Q3 25 | -35.9% | 1.2% | ||
| Q2 25 | -15.4% | 1.7% | ||
| Q1 25 | -62.2% | 2.0% | ||
| Q4 24 | — | 9.2% | ||
| Q3 24 | -57.2% | -8.2% | ||
| Q2 24 | -83.9% | 0.7% | ||
| Q1 24 | 44.3% | -8.0% |
| Q4 25 | $0.32 | $-1.99 | ||
| Q3 25 | $-0.16 | $0.03 | ||
| Q2 25 | $-0.06 | $0.05 | ||
| Q1 25 | $-0.21 | $0.05 | ||
| Q4 24 | $-0.14 | $0.24 | ||
| Q3 24 | $-0.15 | $-0.23 | ||
| Q2 24 | $-0.33 | $0.02 | ||
| Q1 24 | $0.34 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $69.9M |
| Total DebtLower is stronger | — | $1.7M |
| Stockholders' EquityBook value | $-302.0M | $573.2M |
| Total Assets | $465.9M | $883.4M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $69.9M | ||
| Q3 25 | $92.4M | $67.1M | ||
| Q2 25 | $86.1M | $53.9M | ||
| Q1 25 | $114.6M | $66.8M | ||
| Q4 24 | $144.8M | $65.4M | ||
| Q3 24 | $144.7M | $46.0M | ||
| Q2 24 | $189.3M | $25.2M | ||
| Q1 24 | $226.6M | $24.1M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $124.7M | ||
| Q4 24 | — | $124.7M | ||
| Q3 24 | — | $124.6M | ||
| Q2 24 | — | $124.3M | ||
| Q1 24 | — | $135.6M |
| Q4 25 | $-302.0M | $573.2M | ||
| Q3 25 | $-451.4M | $689.0M | ||
| Q2 25 | $-433.5M | $690.6M | ||
| Q1 25 | $-426.2M | $683.4M | ||
| Q4 24 | $-388.7M | $680.7M | ||
| Q3 24 | $-370.2M | $684.8M | ||
| Q2 24 | $-344.2M | $690.4M | ||
| Q1 24 | $-294.3M | $692.3M |
| Q4 25 | $465.9M | $883.4M | ||
| Q3 25 | $364.0M | $1.0B | ||
| Q2 25 | $347.1M | $993.7M | ||
| Q1 25 | $324.0M | $990.7M | ||
| Q4 24 | $343.8M | $1.0B | ||
| Q3 24 | $314.1M | $994.1M | ||
| Q2 24 | $352.3M | $1.0B | ||
| Q1 24 | $373.1M | $1.0B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.18× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $50.1M |
| Free Cash FlowOCF − Capex | — | $47.1M |
| FCF MarginFCF / Revenue | — | 26.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $73.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $50.1M | ||
| Q3 25 | $-4.3M | $30.7M | ||
| Q2 25 | $-31.4M | $15.0M | ||
| Q1 25 | $-22.6M | $9.3M | ||
| Q4 24 | $-35.0M | $18.2M | ||
| Q3 24 | $-35.3M | $28.8M | ||
| Q2 24 | $-7.2M | $10.2M | ||
| Q1 24 | $53.8M | $-11.4M |
| Q4 25 | — | $47.1M | ||
| Q3 25 | — | $22.0M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $137.0K | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $-35.5M | $21.4M | ||
| Q2 24 | $-7.3M | $4.5M | ||
| Q1 24 | $53.8M | $-21.5M |
| Q4 25 | — | 26.4% | ||
| Q3 25 | — | 13.3% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | -68.7% | 12.3% | ||
| Q2 24 | -9.9% | 2.4% | ||
| Q1 24 | 39.0% | -12.8% |
| Q4 25 | 0.0% | 1.7% | ||
| Q3 25 | 0.0% | 5.3% | ||
| Q2 25 | 0.0% | 6.2% | ||
| Q1 25 | 0.0% | 5.7% | ||
| Q4 24 | 0.0% | 8.6% | ||
| Q3 24 | 0.3% | 4.3% | ||
| Q2 24 | 0.1% | 3.1% | ||
| Q1 24 | 0.1% | 6.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 16.15× | ||
| Q2 25 | — | 5.33× | ||
| Q1 25 | — | 2.94× | ||
| Q4 24 | — | 1.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 7.87× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
OIS
| Project Driven | $112.6M | 63% |
| Downhole Technologies | $32.1M | 18% |
| Completion And Production Services | $23.1M | 13% |
| Military And Other Products | $10.7M | 6% |
